Clinical trial
Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece, Who Are Under Treatment With Deferasirox, Based on Standard Clinical Practice.
NCT07352878 is registered in ClinicalTrials.gov with Elpen Pharmaceutical Co. Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece, Who Are Under Treatment With Deferasirox, Based on Standard Clinical Practice.
- Lead sponsor
- Elpen Pharmaceutical Co. Inc.
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 15, 2026
- Completion date
- December 31, 2027
- Enrollment
- 150 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.